Family office · 2 deals
Every published round EWM Group took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Seer | Series A | 3 Sep 2021 | $34m | Participant | SmartCompany, Startup Daily | |
| Seer Medical | Series A | 2021 | $34m | Participant | Startup Daily (Thu 17 Apr 2025), SmartCompany, Startup Daily (Tue 28 Jan 2025), Startup Daily (Tue 7 Jan 2025), Startup Daily (Mon 4 Nov 2024), Giant Leap portfolio |
Companies EWM Group has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Seer | 3 Sep 2021, Series A | 1 | 0 | |
| Seer Medical | 2021, Series A | 1 | 0 |
Fund closes reported for EWM Group, as distinct from the investments it has made.
Companies EWM Group has backed that another company then bought. An exit for the holding, not a deal EWM Group did.
Stories naming EWM Group. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Administrators confirmed a $40 million deal in which Cadwell Industries, TrialCap and Breakthrough Victoria take equity, rescuing Seer Medical from administration; the article also recalls its funding history and 2024 product recall.
Victorian epilepsy device maker Seer Medical has entered voluntary administration, with Pitcher Partners appointed amid a product recall and a cofounder's legal dispute; backers included Breakthrough Victoria and Cochlear.
Seer Medical founding member Dr Pip Karoly won a 2022 Prime Minister's Prize for New Innovators for seizure forecasting research; the medtech has raised over $80 million to date.
Weekly roundup: Seer and Open raise Series A and B rounds, Refundid, Komodo and Earth AI secure funding, Giant Leap closes $15 million for its second fund, Task is acquired for $120 million, and Birchal celebrates its 100th campaign.
Epilepsy diagnostics company Seer has raised a $34 million Series A led by Cochlear, with EWM Group, SG Hiscock and Giant Leap participating, to expand into sleep and cardiac testing and enter overseas markets.
Also SmartCompany